<DOC>
	<DOCNO>NCT01410136</DOCNO>
	<brief_summary>The overall study objective evaluate Chondrofix Osteochondral Allograft ( `` Chondrofix '' ) repair osteochondral lesion knee . This include , limited primary cartilage lesion repair revision fail prior cartilage repair treatment . The study hypothesis Chondrofix Allograft provide pain relief functional improvement demonstrate comparative analysis baseline clinical evaluation 24 month follow-up .</brief_summary>
	<brief_title>Chondrofix Osteochondral Allograft Prospective Study</brief_title>
	<detailed_description>Knee cartilage injury major cause pain functional impairment young middle age adult lead progressive joint degeneration . In response challenge current cartilage repair option , Chondrofix Allograft develop off-the-shelf treatment option add variety cartilage reparation offering . This study multicenter , prospective , post-market clinical outcome study design assess clinical outcome Chondrofix Allograft use treatment primary revision cartilage repair case . Study design include 6 qualified investigational site 50 subject enrol across center 18 month enrollment period . Study subject follow postoperatively 5 year . The Investigators responsible conduct study compliance protocol orthopedic surgeon skilled technique articular cartilage repair .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Generally , follow inclusion criterion must meet , however , complete list . Male nonpregnant female subject 18 70 year ; subject must skeletally mature If female , subject pregnant time surgery plan become pregnant first 24 month study Up two ( 2 ) cartilage lesion ( ) , measure less 8 cm2 , femoral condyle trochlear groove knee Localized knee pain unresponsive conservative treatment ( e.g. , medication , bracing , physical therapy ) and/or previous surgical intervention Generally , potential participant meet follow criterion , eligible study . Additionally , criterion evaluate confirm eligibility list complete list criterion . Concurrent participation another clinical trial Cartilage lesion location implant graft ( ) adequately shoulder Bipolar articular cartilage involvement ( kiss lesion ) ipsilateral compartment ( i.e. , &gt; ICRS Grade 2 oppose articular surface ) Is receive pain medication NSAIDs acetaminophen condition unrelated index knee condition Subject cartilage repair procedure debridement perform conjunction 6 month prior implantation Chondrofix Osteochondral Allograft Prior concurrent total meniscectomy index knee Uncorrected malalignment index knee Have smoke use nicotine product within past 6 month Body Mass Index &gt; 35 ( BMI=kg/m2 ) Has contraindication MRI Requires follow concomitant procedure perform conjunction perform within 6 month prior implantation Chondrofix Allograft : distal realignment , high tibial osteotomy , ligament reconstruction , and/or patellar realignment procedure Septic reactive arthritis systemic disease ( e.g. , rheumatoid arthritis , gout prior history gout pseudo gout ) Sickle cell disease , hemochromatosis , autoimmune disease Unstable cardiovascular , renal , hepatic , endocrine and/or pulmonary disease , cancer uncontrolled diabetes HIV immunedeficient state include subject immunosuppressant therapy Deficiency limit ability perform objective functional assessment operative knee inability adhere postoperative rehabilitation protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Knee</keyword>
	<keyword>Femur</keyword>
	<keyword>Articular cartilage</keyword>
	<keyword>Lesions</keyword>
	<keyword>Defects</keyword>
	<keyword>Osteochondral graft</keyword>
	<keyword>Cartilage treatment</keyword>
	<keyword>Osteochondritis Dissecans</keyword>
	<keyword>OCD</keyword>
</DOC>